Raising the curtain: from the gut lumen to human health and disease—the point of interest for internal medicine DOI Open Access
Rachele Ciccocioppo, Piero Portincasa

Internal and Emergency Medicine, Journal Year: 2023, Volume and Issue: 18(5), P. 1255 - 1258

Published: July 7, 2023

Language: Английский

Role of MMP-2 and MMP-9 in the Relationship between Inflammation, Fibrosis, and Apoptosis during Progression of Non-Alcoholic Fatty Liver Disease and Diagnostic Significance of Plasma Levels of Their Active Forms DOI
И. В. Курбатова,

Lyudmila Topchieva,

О. П. Дуданова

et al.

Biochemistry (Moscow), Journal Year: 2024, Volume and Issue: 89(11), P. 1998 - 2022

Published: Nov. 1, 2024

Language: Английский

Citations

0
Editorial: Rising stars in cardiovascular endocrinology 2022 DOI Creative Commons
Óscar Lorenzo

Frontiers in Endocrinology, Journal Year: 2023, Volume and Issue: 14

Published: March 13, 2023

EDITORIAL article Front. Endocrinol., 13 March 2023Sec. Cardiovascular Endocrinology Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1175403

Language: Английский

Citations

1
Association of endotoxaemia with low grade inflammation, metabolic syndrome and distinct response to lipopolysaccharide in type 1 diabetes DOI Creative Commons
Aleksejs Fedulovs, Leonora Pahirko, Kaspars Jēkabsons

et al.

Research Square (Research Square), Journal Year: 2023, Volume and Issue: unknown

Published: May 8, 2023

Abstract Mechanisms of endotoxaemia as a source low grade inflammation in type 1 diabetes (T1D) are not clear enough. We investigated the levels lipopolysaccharide (LPS), binding protein (LBP), endogenous anti-endotoxin core antibodies (EndoCAb IgG and IgM) high sensitivity C reactive (hsCRP) T1D. 74 patients with T1D 33 control subjects were included. Higher hsCRP EndoCAb observed compared to (p = 0.002 p 0.091, respectively). LBP (\(\beta\) 0.29 (0.08; 0.50), 0.007), 0.25 (0.04; 0.46), 0.019) LPS significantly associated In contrast situation group, did correlate LBP, EndoCAb, leukocytes HDL Within metabolic syndrome (MS) had higher level without MS (MS 0.42 (0.35–0.56), no 0.34 (0.3–0.4), 0.009) was (OR 3.3 (1.6; 6.8), 0.001) IgM 0.43 (0.20; 0.91), 0.027). To conclude, is inflammation, distinct response

Language: Английский

Citations

1
The fatty liver as testimonial of systemic diseases. Further evidence from rheumatoid arthritis and confirmation for a leading role of internal medicine DOI
Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa

et al.

European Journal of Internal Medicine, Journal Year: 2023, Volume and Issue: 118, P. 41 - 42

Published: Oct. 21, 2023

Language: Английский

Citations

1
Raising the curtain: from the gut lumen to human health and disease—the point of interest for internal medicine DOI Open Access
Rachele Ciccocioppo, Piero Portincasa

Internal and Emergency Medicine, Journal Year: 2023, Volume and Issue: 18(5), P. 1255 - 1258

Published: July 7, 2023

Language: Английский

Citations

0